Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.

Reinhard H, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rossing P, Jacobsen PK.

Cardiovasc Diabetol. 2012 Mar 5;11:19. doi: 10.1186/1475-2840-11-19.

2.

Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate.

Reinhard H, Hansen PR, Persson F, Tarnow L, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rossing P, Jacobsen PK.

Nephrol Dial Transplant. 2011 Oct;26(10):3242-9. doi: 10.1093/ndt/gfr009. Epub 2011 Mar 3.

PMID:
21372253
3.

N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.

Cosson E, Nguyen MT, Pham I, Pontet M, Nitenberg A, Valensi P.

Diabet Med. 2009 Sep;26(9):872-9. doi: 10.1111/j.1464-5491.2009.02788.x.

PMID:
19719707
4.

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.

Reinhard H, Wiinberg N, Hansen PR, Kjær A, Petersen CL, Winther K, Parving HH, Rossing P, Jacobsen PK.

Cardiovasc Diabetol. 2011 Aug 3;10:71. doi: 10.1186/1475-2840-10-71.

5.

Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: association with microalbuminuria and silent coronary artery disease.

Nguyen MT, Cosson E, Valensi P, Poignard P, Nitenberg A, Pham I.

Diabetes Metab. 2011 Sep;37(4):343-50. doi: 10.1016/j.diabet.2010.12.006. Epub 2011 Mar 12.

PMID:
21398163
6.

Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients.

Yamazaki M, Ogawa T, Tamei N, Ando Y, Nitta K.

Heart Vessels. 2011 Jul;26(4):421-7. doi: 10.1007/s00380-010-0066-4. Epub 2010 Dec 3.

PMID:
21127887
7.

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.

Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.

PMID:
20102869
8.

Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.

Caselli C, Prontera C, Liga R, De Graaf MA, Gaemperli O, Lorenzoni V, Ragusa R, Marinelli M, Del Ry S, Rovai D, Giannessi D, Aguade-Bruix S, Clemente A, Bax JJ, Lombardi M, Sicari R, Zamorano J, Scholte AJ, Kaufmann PA, Knuuti J, Underwood SR, Clerico A, Neglia D.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):757-64. doi: 10.1161/ATVBAHA.115.306818. Epub 2016 Feb 11.

9.
10.

Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.

Helal I, Belhadj R, Mohseni A, Bazdeh L, Drissa H, Elyounsi F, Abdallah TB, Abdelmoula J, Kheder A.

Saudi J Kidney Dis Transpl. 2010 Mar;21(2):262-8.

11.
12.

NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.

Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, Rossignol P, Heine GH.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1978-1988. Epub 2016 Aug 11.

13.

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria.

Reinhard H, Nybo M, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rasmussen LM, Rossing P, Jacobsen PK.

Cardiovasc Diabetol. 2011 Jul 29;10:70. doi: 10.1186/1475-2840-10-70.

14.

NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.

Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.

Coron Artery Dis. 2008 Nov;19(7):481-7. doi: 10.1097/MCA.0b013e32830b4d0e.

PMID:
18923244
15.

Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.

Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J.

Heart. 2009 Feb;95(4):297-303. doi: 10.1136/hrt.2008.145425. Epub 2008 Aug 15.

PMID:
18708421
16.

Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.

Siva Sankara C, Rajasekhar D, Vanajakshamma V, Praveen Kumar BS, Vamsidhar A.

Indian Heart J. 2015 Jul-Aug;67(4):318-27. doi: 10.1016/j.ihj.2015.04.023. Epub 2015 May 20.

17.

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients.

Reinhard H, Garde E, Skimminge A, Åkeson P, Ramsøy TZ, Winther K, Parving HH, Rossing P, Jacobsen PK.

Cardiovasc Diabetol. 2012 Oct 3;11:119. doi: 10.1186/1475-2840-11-119.

18.

Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.

Iwasaki M, Joki N, Tanaka Y, Ikeda N, Hayashi T, Kubo S, Asakawa T, Takahashi Y, Hirahata K, Imamura Y, Hase H.

Nephrology (Carlton). 2013 Jul;18(7):497-504. doi: 10.1111/nep.12063.

PMID:
23574011
19.

Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.

Krzesiński P, Uziebło-Życzkowska B, Gielerak G, Stańczyk A, Piotrowicz K, Piechota W, Smurzyński P, Skrobowski A.

Adv Clin Exp Med. 2017 Mar-Apr;26(2):295-301. doi: 10.17219/acem/33554.

20.

Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.

Islamoglu F, Ozcan K, Apaydin AZ, Soydas C, Bayindir O, Durmaz I.

Tex Heart Inst J. 2008;35(2):111-8.

Supplemental Content

Support Center